Gangcai Zhu

central south university

H指数:27

被引数:1,861

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic Associations of BMI and Metabolic Syndrome With Outcomes After Anti-PD-1 Therapy in Recurrent or Metastatic Nasopharyngeal Carcinoma

复发或转移性鼻咽癌患者接受抗PD-1治疗后，BMI和代谢综合征与预后的相关性研究

Immunology

IF5

2026-09-100

PRE

Metabolic predictors of response to immunotherapy in locally advanced or metastatic esophageal cancer: unveiling the obesity paradox

局部晚期或转移性食管癌对免疫治疗的代谢预测因子：揭示肥胖悖论

Scientific Reports

IF3.9

2026-09-090

OAAI

Neuroimmune Interactions in Inflammatory Skin and Intestinal Diseases

神经免疫相互作用在炎症性皮肤和肠道疾病中的作用

Journal of Inflammation Research

IF4.1

2026-09-070

Targeting lysosomal protease CTSL promotes anti-tumor immunity and sensitizes HNSCC to PD-1 blockade by stabilizing PDK1 and activating Akt–PD-L1 axis

靶向溶酶体蛋白酶CTSL通过稳定PDK1并激活Akt–PD-L1轴，促进抗肿瘤免疫并使头颈鳞状细胞癌（HNSCC）对PD-1阻断敏感化。

Neoplasia

IF7.7

2025-09-160

PREAI

Peripheral eosinophils and immunotherapy response in patients with recurrent or metastatic HNSCC

外周嗜酸性粒细胞和免疫疗法应答在复发性或转移性HNSCC患者中的关系

SCIENTIFIC REPORTS

IF3.9

2025-05-190

Functional inorganic nanoparticles in cancer: Biomarker detection, imaging, and therapy

APL MATERIALS

IF4.5

2024-10-010

The Gastric Connection: Serum Gastric Biomarkers, Metabolic Syndrome and Transition in Metabolic Status

inflammation research

IF4.1

2024-09-010

TGFBI: A novel therapeutic target for cancer

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2024-06-010

PRE

Postoperative tumor treatment strategies: From basic research to clinical therapy

肿瘤术后治疗策略: 从基础研究到临床治疗

View

IF8.5

2024-05-291

OAAI

3D bioprinting in otorhinolaryngology: from bench to clinical application

INTERNATIONAL JOURNAL OF BIOPRINTING

IF6

2024-04-292

Emerging biomaterials for tumor immunotherapy

用于肿瘤免疫治疗的新兴生物材料

BIOMATERIALS RESEARCH

IF9.6

2023-05-1636

OAAI

Tumor Histological Grade and Immunotherapy Response in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY

IF5.6

2022-06-014

The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site

原发和远处HPV相关咽部转移患者的预后

ORAL ONCOLOGY

IF3.9

2022-02-017

OAAI

Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY

IF5.6

2022-01-0115

Metabolic Reprogramming and Immune Evasion in Nasopharyngeal Carcinoma

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-09-0929

OAAI

Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2021-08-0112

OAAI

Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-04-0732

OAAI

Association Between Vitamin D Exposure and Head and Neck Cancer: A Systematic Review With Meta-Analysis

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-02-2319

OAAI

The Molecular Landscape and Biological Alterations Induced by PRAS40-Knockout in Head and Neck Squamous Cell Carcinoma

FRONTIERS IN ONCOLOGY

IF3.3

2021-01-086

OAAI

Proteomic analysis of hypopharyngeal and laryngeal squamous cell carcinoma sheds light on differences in survival

下咽和喉鳞状细胞癌的蛋白质组学分析揭示了生存的差异

SCIENTIFIC REPORTS

IF3.9

2020-11-107

OAAI

Gangcai Zhu

个人简介

教育背景

工作经历

荣誉奖项

研究方向